vTv Therapeutics (VTVT) Insider Trading & Ownership $15.63 -0.41 (-2.56%) (As of 12/2/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends vTv Therapeutics (NASDAQ:VTVT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.34%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$17,031.60Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$100,050.00 Get VTVT Insider Trade Alerts Want to know when executives and insiders are buying or selling vTv Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VTVT Insider Buying and Selling by Quarter Ad Paradigm PressMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. vTv Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/28/2022John A FryDirectorBuy513$33.20$17,031.60 12/20/2021Ronald O PerelmanMajor ShareholderSell2,175$46.00$100,050.00 (Data available from 1/1/2013 forward) VTVT Insider Trading Activity - Frequently Asked Questions Who is on vTv Therapeutics's Insider Roster? The list of insiders at vTv Therapeutics includes John A Fry, and Ronald O Perelman. Learn more on insiders at VTVT. What percentage of vTv Therapeutics stock is owned by insiders? 1.34% of vTv Therapeutics stock is owned by insiders. Learn more on VTVT's insider holdings. vTv Therapeutics Key ExecutivesMr. Paul J. Sekhri M.Sc. (Age 66)CEO, President & Chairman of the Board Compensation: $650.91kMr. Steven Tuch M.B.A. (Age 55)Executive VP & CFO Compensation: $465.25kDr. Carmen Valcarce Ph.D.Chief Scientific Officer & Executive VPMs. Elizabeth M. Keiley (Age 58)Executive VP & General Counsel Mr. Richard S. Nelson (Age 54)Executive VP of Corporate Development & Director Compensation: $201.08kDr. Thomas Strack M.D.Ph.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies LFVN Insider Trades SCPH Insider Trades ADAP Insider Trades CABA Insider Trades HRTX Insider Trades ZURA Insider Trades VTYX Insider Trades ENTA Insider Trades INZY Insider Trades EDIT Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024?Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in Buybacks This page (NASDAQ:VTVT) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding vTv Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share vTv Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
